651 |
Optimal Treatment for Below-the-knee |
Young-Guk Ko |
May. 16. 11 |
650 |
ACHILLES Study (DES for BTK) |
Andrej Schmidt |
May. 16. 11 |
649 |
Rationale for the Use of Single Pill Combination and Asian Data of ARB/CCB SPC |
Seungwoo Park |
May. 16. 11 |
648 |
Improving Effect of ARB to Asian Hypertension Patients |
Jeong Bae Park |
May. 16. 11 |
647 |
A Single Center Clinical Experience Using Biolimus-Eluting Stent with Biodegradable Polymer |
Il Yi |
May. 16. 11 |
646 |
BioMatrixTM: The Next Generation Biodegradable Polymer Technology - Korean Experience |
Kyung Woo Park |
May. 16. 11 |
645 |
Evaluation of Effectiveness and Safety of BioMatrixTM - Biolimus A9TM stEnt in patients with AcUTe coronary sYndrome |
Young Joon Hong |
May. 16. 11 |
644 |
Evidence Based Medicine: Does BioMatrixTM Bring Patient Benefit? - 3 Yr/Subgroup Follow Up from LEADERS Trial |
Eberhard Grube |
May. 16. 11 |
643 |
The Real World Data & Experience of Zilver-PTX |
Bryan Ping-Yen Yan |
May. 16. 11 |
642 |
The Drug Eluting Stent in the SFA |
Mark W. Burket |
May. 16. 11 |